03.01.2026
... Ibu-Tec 4,94%, BASF 2,61%, Lanxess 2,58%, Evotec 2,49%, Sartorius 0, ... BASF -0,84% , Biogen Idec -1,31% , Lanxess -1,68% , Gilead Sciences -1,86% , Amgen ...
27.12.2025
... Sanofi -0,62%, BASF -1,98%, Lanxess -2,06%, Epigenomics -6,99%, Paion ... Novartis 5,28% , Roche GS 5,1% , Lanxess 4,46% , Fresenius 3,88% , Baxter ...
20.12.2025
... 41%, Pfizer -2,55%, Valneva -4,45%, Lanxess -4,55%, Epigenomics -6,99%, Paion -11 ... 8,13% , BB Biotech 8,06% , Lanxess 7,45% , Sartorius 7,04% , Merck ...
13.12.2025
... 59% vor Baxter International 3,29%, Lanxess 2,77%, BASF 2,54%, Roche GS ... Idec 9,11% , Baxter International 4,93% , Lanxess 4,64% , Merck KGaA 4,62% , ...
06.12.2025
... MorphoSys 0%, Biogen Idec -0,43%, Lanxess -0,74%, Sanofi -0,89%, Baxter ... -3,97% , Paion -5,2% , Epigenomics -8,58% , Lanxess -10,02% , Medigene -12,88 ...
02.12.2025
... Roundup-Fall anzunehmen. LXS-Die Lanxess-Aktie verliert ihren Platz im ...
29.11.2025
... 10,51%, Merck Co. 7,23%, Lanxess 6,85%, Valneva 6,79%, BB Biotech ... % , Medigene -12,88% , GlaxoSmithKline -14,1% , Lanxess -17,05% , Evotec -18,01 ...